News

News brief: antiviral pill for COVID, Jan. 6 probe, Putin's news conference

NPR

New York, NY
(December 23, 2021)

Kris White, PhD, discusses the new antiviral pill used to treat COVID-19, including the Omicron variant.

Tags: COVID-19 Facts and Resources, Icahn School of Medicine at Mount Sinai, Kris M White, PhD

For Media Inquiries

Phone:

212-241-9200 212-241-9200

Fax:

212-241-6512 212-241-6512

Email:

NewsMedia@mssm.edu

If you are a member of the media and are on deadline, please call the Press Office or page the press officer on call.

View All Media Contacts

For Media Inquiries

Phone:

212-241-9200 212-241-9200

Fax:

212-241-6512 212-241-6512

Email:

NewsMedia@mssm.edu

If you are a member of the media and are on deadline, please call the Press Office or page the press officer on call.

View All Media Contacts

Researcher using microscope

Press Release

Mount Sinai Researchers Awarded $16 Million to Develop Antivirals Against Viruses With Pandemic Potential

May 31, 2022 View All Press Releases

Press Release

Pfizer assures that anticovid pills are also effective against omicron

Jan 18, 2022 View All Press Releases

Press Release

UCSF QBI and Icahn School of Medicine at Mount Sinai Scientists Report New Preclinical Data Published in Science on Potential Best-in-Class COVID-19 Anti-Viral Treatment: Plitidepsin

Jan 27, 2021 View All Press Releases